30556160|t|miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3beta in Alzheimer's disease.
30556160|a|As the most common neurodegenerative disease, Alzheimer's disease (AD) is characterized by memory, perception, and behavioral damage, which may ultimately lead to emotional fluctuation and even lethal delirium. Increasing studies indicate that microRNAs (miRNAs) are associated with pathological features of AD. However, the role of miR-219-5p in AD progression is still unclear. In this study, the functions of miR-219-5p were analyzed in vitro and in vivo. miR-219-5p was notably overexpressed in brain tissues of patients with AD. The overexpression of miR-219-5p activated the phosphorylation of Tau-Ser198, Tau-Ser199, Tau-Ser201, and Tau-Ser422. We further showed that miR-219-5p could mediate a decrease in the protein levels of tau-tubulin kinase 1 (TTBK1) and glycogen synthase kinase 3beta (GSK-3beta) by directly binding to their 3'-untranslated region, thereby promoting the phosphorylation of tau in SH-SY5Y Cells. Rescue experiments further revealed that the phosphorylation of tau-mediated by miR-219-5p was dependent on the inhibition of TTBK1 and GSK-3beta. Moreover, suppressing the expression of both TTBK1 and GSK-3beta using miR-219-5p remarkably rescued AD-like symptoms in amyloid precursor protein/presenilin 1 mice. Our findings indicate that the upregulation of TTBK1 and GSK-3beta mediated by the loss of miR-219-5p is a possible mechanism that contributes to tau phosphorylation and AD progression.
30556160	20	23	tau	Gene	4137
30556160	53	58	TTBK1	Gene	84630
30556160	63	72	GSK-3beta	Gene	2932
30556160	76	95	Alzheimer's disease	Disease	MESH:D000544
30556160	116	141	neurodegenerative disease	Disease	MESH:D019636
30556160	143	162	Alzheimer's disease	Disease	MESH:D000544
30556160	164	166	AD	Disease	MESH:D000544
30556160	223	229	damage	Disease	MESH:D020263
30556160	298	306	delirium	Disease	MESH:D003693
30556160	405	407	AD	Disease	MESH:D000544
30556160	444	446	AD	Disease	MESH:D000544
30556160	613	621	patients	Species	9606
30556160	627	629	AD	Disease	MESH:D000544
30556160	697	700	Tau	Gene	4137
30556160	709	712	Tau	Gene	4137
30556160	721	724	Tau	Gene	4137
30556160	737	740	Tau	Gene	4137
30556160	833	853	tau-tubulin kinase 1	Gene	84630
30556160	855	860	TTBK1	Gene	84630
30556160	866	896	glycogen synthase kinase 3beta	Gene	2932
30556160	898	907	GSK-3beta	Gene	2932
30556160	1003	1006	tau	Gene	4137
30556160	1010	1017	SH-SY5Y	CellLine	CVCL:0019
30556160	1089	1092	tau	Gene	4137
30556160	1151	1156	TTBK1	Gene	84630
30556160	1161	1170	GSK-3beta	Gene	2932
30556160	1217	1222	TTBK1	Gene	84630
30556160	1227	1236	GSK-3beta	Gene	56637
30556160	1273	1275	AD	Disease	MESH:D000544
30556160	1293	1318	amyloid precursor protein	Gene	11820
30556160	1319	1331	presenilin 1	Gene	19164
30556160	1332	1336	mice	Species	10090
30556160	1385	1390	TTBK1	Gene	84630
30556160	1395	1404	GSK-3beta	Gene	2932
30556160	1484	1487	tau	Gene	4137
30556160	1508	1510	AD	Disease	MESH:D000544
30556160	Association	4137	84630
30556160	Association	2932	4137
30556160	Association	MESH:D000544	84630
30556160	Association	MESH:D000544	56637
30556160	Association	MESH:D000544	2932
30556160	Association	MESH:D000544	4137

